Indonesia is one of the major white shrimp (L. vannamei ) producer . The export value in 2025 was USD 1.78 billion (+11% YoY), with December 2025 rebound sharply after the radioactive shrimp resolved. However, Indonesia white shrimp industry is facing unpredictable situation due to disease problem. There are several major diseases occurrence in the farm in Indonesia such as AHPND (Acute hepatopancreatic necrosis disease), white feces/ EHP (Enterocytozoon hepatopenaei) , white spot disease , and infectious myonecrosis disease.
This study is to understand the disease occurrence and pattern in shrimp farm in Indonesia. This is important to set strategy for disease mitigation. Disease / pathogen monitoring has conducted to major shrimp producer area in Indonesia from January 2023 to December 2025 . Total samples tested was 4396 samples in 2023, 3314 samples in 2024, and 12369 samples in 2025. The samples were taken from farm in Java, Sumatera, Nusa Tenggara and Sulawesi . Diagnosis in this study was focused on AHPND, EHP, WSSV (white spot syndrome virus) and IMNV agents/substances. Polymerase Chain Reactio n (PCR) test has been used as diagnostic technique in this study.
The result showed that based on area, there were increased of disease occurrence in all area from 2023 to 2025, particularly in South Sumatera, West-Central Java and Sulawesi.
The diseases occurrence was stable in Q2, Q3, Q4 in 2023, 2024 and 2024 with average 14%. However, there was significant increase in Q1 from 9% in 2023 to 21% in 2024 and 19% in 2025.
In 2024 AHPND was the major pathogen detected followed by EHP, WSSV and IMNV. While in 2025 EHP positive samples increase double and was the major pathogen detected followed by AHPND, WSSV and IMNV. The disease pattern in Indonesia was changed with the increased of EHP occurrence in 2024 and 2025. The disease also detected increase in Q1 (January, February and March).